Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy [0.03%]
达沙替尼治疗慢性髓系白血病患者成功妊娠及分娩病例报告
Monika Conchon,Sabri S Sanabani,Mariana Serpa et al.
Monika Conchon et al.
Here we report the case of an 18-year-old woman with chronic myeloid leukemia (CML) who became pregnant while undergoing treatment with dasatinib. Before pregnancy, she received imatinib mesylate therapy but could not tolerate the treatment...
Case Reports
Advances in hematology. 2010:2010:136252. DOI:10.1155/2010/136252 2010
Quality, stability, and safety data of packed red cells and plasma processed by gravity separation using a new fully integrated hollow-fibre filter device [0.03%]
新型全整合式空心纤维滤器装置离心制备悬浮红细胞和血浆的质量、稳定性和安全性数据
T Brune,K Hannemann-Pohl,K Nißle et al.
T Brune et al.
Background. We developed a completely closed system based on gravity separation without centrifugation steps for separation of whole blood. With this new system we compared quality and stability of the processed blood components (PRC and pl...
Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias [0.03%]
靶向铁调素-铁调节蛋白轴以诊断和治疗贫血症
Elizabeta Nemeth
Elizabeta Nemeth
The hepatic peptide hormone hepcidin regulates dietary iron absorption, plasma iron concentrations, and tissue iron distribution. Hepcidin acts by causing the degradation of its receptor, the cellular iron exporter ferroportin. The loss of ...
ETV6-RUNX1 Rearrangement in Tunisian Pediatric B-Lineage Acute Lymphoblastic Leukemia [0.03%]
突尼斯儿童B细胞急性淋巴细胞白血病中ETV6-RUNX1易位
Abir Gmidène,Hatem Elghezal,Hlima Sennana et al.
Abir Gmidène et al.
In this study, Forty-one out of fifty-seven Tunisian children with B-lineage acute lymphoblastic leukemia (B-ALL), and without cytogenetically detectable recurrent abnormalities at the time of the diagnosis, were evaluated by fluorescence i...
Myelofibrosis-associated lymphoproliferative disease: retrospective study of 16 cases and literature review [0.03%]
骨髓纤维化相关淋巴增生性疾病：16例临床分析及文献复习
A Etienne,B Gruson,D Chatelain et al.
A Etienne et al.
Background. To better describe the clinical, biological, and the outcome of non-Hodgkin's lymphoma (NHL) with, at the initial presentation, bone marrow fibrosis (MF). Patients and Methods. From January 2001 to January 2007, 16 eligible pati...
Does adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia? [0.03%]
脂蛋白脂肪酸是否作为B细胞慢性淋巴细胞白血病中抗血管生成因子？
Stefano Molica,Giovanna Digiesi,Angelo Vacca et al.
Stefano Molica et al.
Angiogenesis is involved in the pathogenesis of B-cell chronic lymphocytic leukemia (CLL), and high microvascular density has been found in CLL to be associated with a poor prognosis. In this study, we assessed serum levels of adiponectin i...
Clinico-haematological profile of acute megakaryoblastic leukaemia: report of five cases [0.03%]
急性巨核细胞白血病的临床血液学特征五例报告
Sunita Sharma,Anita Nangia,Sonal Jain Malhotra et al.
Sunita Sharma et al.
Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia. Although known as a distinct entity for a very long time, because of lack of distinct clinical features and morphological criteria, it is difficult to diagn...
Case Reports
Advances in hematology. 2009:2009:461912. DOI:10.1155/2009/461912 2009
beta-Thalassaemia Major in a Spanish Patient due to a Compound Heterozygosity for CD39 C --> T/-28 A --> C [0.03%]
一名由于CD39 C-->T和-28 A-->C组成的复合杂合子而导致的地中海贫血患者案例
Soledad Gamarra,Guillermo Garcia-Effron,Carmen Monteserin et al.
Soledad Gamarra et al.
A Spanish male patient with beta-thalassaemia major was studied. Compound heterozygosity was found for one of the most common beta-globin gene mutations in the Spanish population (codon 39 C --> T) and for a mutation in the TATA box element...
Case Reports
Advances in hematology. 2009:2009:476342. DOI:10.1155/2009/476342 2009
David M Mintzer,Shira N Billet,Lauren Chmielewski
David M Mintzer
Objective. Drugs can induce almost the entire spectrum of hematologic disorders, affecting white cells, red cells, platelets, and the coagulation system. This paper aims to emphasize the broad range of drug-induced hematological syndromes a...
Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemia [0.03%]
门诊氟达拉滨联合皮下注射阿伦单抗治疗亚洲复发/难治慢性淋巴细胞白血病患者的疗效
William Y K Hwang,Claire Dearden,Yvonne S M Loh et al.
William Y K Hwang et al.
Background. Intravenous alemtuzumab and fludarabine are effective in combination for the treatment of chronic lymphocytic leukemia (CLL), but require hospital visits for intravenous injection. We performed a pilot study to assess the safety...